| RVNC Snapshot | |
|---|---|
| Revance Therapeutics, Inc., a biotechnology company, is dedicated to the development, manufacture, and marketing of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company is headquartered in Newark, California. | |
| VALUATION DATA | |
| Market Capitalization | $372,051,000 | Price to Sales | 4.00 |
| Earnings per Share | $-3.8300 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $3.2900 |
| 52 Week High | $1.839 |
| 52 Week Low | $12.3 |
| 50-Day Moving Average | $2.803 |
| 200-Day Moving Average | $-2.257 |
| All data are from Alpha Vantage as of today. For more infomation on RVNC see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search